Deal Tracker · Regions

MENA pharma investment deals

5 equity / investment deals in MENA tracked by EPT (2024–2026). Most active: ATCO Pharma, Casablanca Stock Exchange IPO, Hikma Ventures & Immuneel Therapeutics. Latest: Hikma Ventures → Rem3dy Health (Equity / Investment, 11 Nov 2026).

5
deals tracked
4
announced in 2026
$237m
disclosed value (2 deals)
100%
investment, the top deal type
  • EPT has tracked 5 MENA pharma investment deals (2024–2026), 4 of them announced in 2026.
  • The countries that appear most often are Egypt (2), India (1), Morocco (1) & Oman (1).
  • Values were disclosed for 2 of 5 deals, totalling $237m; the largest is Casablanca Stock Exchange IPO → Laprophan ($225m, 28 Oct 2026).

Countries involved

Egypt (2) · India (1) · Morocco (1) · Oman (1) · Saudi Arabia (1) · UAE (1)

Largest disclosed deals

Questions

How many MENA pharma investment deals has EPT tracked?
5 as of 11 Nov 2026, covering 2024–2026; 4 were announced in 2026. The most recent is Hikma Ventures → Rem3dy Health (Equity / Investment, 11 Nov 2026).
What is the largest disclosed MENA pharma investment deal?
Casablanca Stock Exchange IPO → Laprophan: $225m (Equity / Investment, 28 Oct 2026); Immuneel Therapeutics → Taiba Healthcare: $12m (Equity / Investment, 30 Jul 2024). Values are as announced by the parties.
Which countries appear most in MENA pharma investment deals?
Egypt (2), India (1), Morocco (1), Oman (1), Saudi Arabia (1), UAE (1) — counting where the parties are based and the markets the deals cover.

Browse deals

By region

GCC (83) · MENA (66) · Africa (17) · Latin America (17) · Southeast Asia (17) · Global (LMICs) (14) · CIS & Central Asia (13) · Türkiye (5) · Global ex-US (1)

By country

Saudi Arabia (69) · UAE (61) · China (31) · Egypt (27) · United States (26) · Oman (20) · India (19) · Switzerland (18) · Jordan (14) · South Korea (14) · Kazakhstan (13) · Algeria (12) · Türkiye (12) · United Kingdom (11) · Brazil (10) · Kuwait (10) · Iraq (8) · Morocco (8) · Bahrain (7) · Malaysia (7) · Spain (7) · Argentina (6) · Germany (6) · Indonesia (6) · Philippines (6) · Qatar (6) · Italy (5) · Mexico (5) · Vietnam (5) · France (4) · Taiwan (4) · Tunisia (4) · Canada (3) · Chile (3) · Denmark (3) · Greece (3) · Japan (3) · Lebanon (3) · Nigeria (3) · Pakistan (3) · South Africa (3) · Sweden (3) · Thailand (3) · Azerbaijan (2) · Colombia (2) · Ireland (2) · Kenya (2) · Libya (2) · Netherlands (2) · Singapore (2) · Uruguay (2) · Uzbekistan (2)

By year

2026 (193) · 2025 (27) · 2024 (6) · 2022 (3) · 2021 (2)

By therapeutic area

Multi-therapy (64) · Oncology (30) · Metabolic / Diabetes (27) · Cardiovascular (17) · Vaccines (15) · Immunology / Inflammation (13) · Rare / Orphan (9) · Infectious Disease (8) · CNS / Neurology (6) · Ophthalmology (6) · Consumer health (5) · Women's Health (4) · Respiratory (2)